Enzyme Tech, Microbes, Bioinnovation: The Digest’s 2020 Multi-Slide Guide to Novozymes

February 14, 2021 |

“Despite the COVID-19 pandemic” is something positive to see…and Novozymes shares that 2020 was a resilient year for the company and they expect 2021 to be even better with an outlook of 2-6% organic sales growth and solid EBIT margin. Take a peek into their 2020 financials, 2021 outlook and plans, how their products are used in 30+ industries and 140 countries and more.

Prev1 of 68
Use your ← → (arrow) keys to browse

Print Friendly, PDF & Email

Category: 8-Slide Guide

Thank you for visting the Digest.